Regulation of the Action of Early Mitotic Inhibitor 1 on the Anaphase-promoting Complex/cyclosome by Cyclin-dependent Kinases
Overview
Affiliations
Cell cycle regulation is characterized by alternating activities of cyclin-dependent kinases (CDKs) and of the ubiquitin ligase anaphase promoting complex/cyclosome (APC/C). During S-phase APC/C is inhibited by early mitotic inhibitor 1 (Emi1) to allow the accumulation of cyclins A and B and to prevent re-replication. Emi1 is degraded at prophase by a Plk1-dependent pathway. Recent studies in which the degradation pathway of Emi1 was disrupted have shown that APC/C is activated at mitotic entry despite stabilization of Emi1. These results suggested the possibility of additional mechanisms other than degradation of Emi1, which release APC/C from inhibition by Emi1 upon entry into mitosis. In this study we report one such mechanism, by which the ability of Emi1 to inhibit APC/C is negatively regulated by CDKs. We show that in Plk1-inhibited cells Emi1 is stabilized and phosphorylated, that Emi1 is phosphorylated by CDKs in mitotic but not S-phase cell extracts, and that Emi1 phosphorylation by mitotic cell extracts or purified CDKs markedly reduces the ability of Emi1 to bind and to inhibit APC/C. Finally, we show that the addition of extracts from S-phase cells to extracts from mitotic cells protects Emi1 from CDK-mediated inactivation.
The role of Fbxo5 in the development of human malignant tumors.
Gao J, Yang D, Cao R, Huang H, Ma J, Wang Z Am J Cancer Res. 2022; 12(4):1456-1464.
PMID: 35530293 PMC: 9077063.
APC/C: current understanding and future perspectives.
Yamano H F1000Res. 2019; 8.
PMID: 31164978 PMC: 6534075. DOI: 10.12688/f1000research.18582.1.
Posing the APC/C E3 Ubiquitin Ligase to Orchestrate Cell Division.
Watson E, Brown N, Peters J, Stark H, Schulman B Trends Cell Biol. 2018; 29(2):117-134.
PMID: 30482618 PMC: 6340778. DOI: 10.1016/j.tcb.2018.09.007.
EMI1 switches from being a substrate to an inhibitor of APC/C to start the cell cycle.
Cappell S, Mark K, Garbett D, Pack L, Rape M, Meyer T Nature. 2018; 558(7709):313-317.
PMID: 29875408 PMC: 6035873. DOI: 10.1038/s41586-018-0199-7.
de Castro I, Sales Gil R, Ligammari L, Di Giacinto M, Vagnarelli P Oncotarget. 2018; 9(8):7763-7773.
PMID: 29487689 PMC: 5814256. DOI: 10.18632/oncotarget.23666.